Rare diseases
Investigational molecules
Locations
Back to Hungary75 clinical trials in Bekescsaba, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
HungaryStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
HungaryA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
HungaryStudy of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis
HungaryLong-Term Study of Imeroprubart in Adults With Graves' Disease
HungaryA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
HungaryStudy of icotrokinra for adults with moderately to severely active Crohn's disease
HungaryTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
HungaryStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
HungaryEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
HungaryEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
HungaryStudy on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies evaluate new combination therapies and interventions for reducing major cardiac events.
Several trials are investigating novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Comprehensive research into inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis. Multiple trials are evaluating new therapeutic approaches for moderate to severe cases.
Focus on long-term efficacy and safety of various treatment options for inflammatory bowel conditions.
Advanced research into dyslipidemia and hypertriglyceridemia, with trials examining new therapeutic approaches for managing blood lipid levels and associated conditions.
Studies aim to improve treatment options for patients with various metabolic disorders and associated cardiovascular risks.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
